Kezar Life Sciences GAAP EPS of -$1.53 beats by $0.42 (NASDAQ:KZR)
Group 1 - The article does not provide any relevant content regarding company or industry insights [1]
Group 1 - The article does not provide any relevant content regarding company or industry insights [1]